Company
Juno Therapeutics, Inc. (0001594864)
Standardized SEC financial data for Juno Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001594864 · Biological Products, (No Diagnostic Substances).
Operating margin
-400.3%
Net margin
-390.7%
Revenue growth (YoY)
41.0%
Return on equity
-41.8%
ROIC
-42.9%
Free cash flow
-$286.0M
Debt / equity
0.01×
Current ratio
3.61×
Ratios for fiscal year 2017, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 |
|---|---|---|
| Revenue | $79.4M | $111.9M |
| R&D expense | $264.3M | $451.5M |
| SG&A expense | $70.7M | $108.1M |
| Operating income | -$255.6M |
Balance sheet
| USD | FY2016 | FY2017 |
|---|---|---|
| Cash & equivalents | $187.9M | $232.8M |
| Total current assets | $772.3M | $753.4M |
| Property, plant & equipment | $81.7M | $133.1M |
| Goodwill | $221.3M |
Cash flow
| USD | FY2016 | FY2017 |
|---|---|---|
| Operating cash flow | -$189.8M | -$225.0M |
| Capital expenditures | $56.2M | $60.9M |
| Free cash flow | -$246.1M | -$286.0M |
| Investing cash flow | $88.6M |
Get 0001594864 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001594864/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001594864/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"